C12N 2770/26034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/26034 (Use of virus or viral component as vaccine) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 5
- Assignees
- 2
- Inventors
- 5
- Latest grant
- 5 Dec 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 2 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
By publication year.
Recent patents
- Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines26 Feb 2015US 2015/0056231 A1Folia Biotech Inc.
- Virus-like particles and process for preparing same11 Sep 2014US 2014/0255439 A1Folia Biotech Inc.
- Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response5 Jun 2014US 2014/0154288 A1Folia Biotech Inc.
- Malva mosaic virus and virus-like particles and uses thereof5 May 2011US 2011/0104191 A1Universite Laval
- Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens16 Dec 2010US 2010/0316665 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.